| 英文别名 |
IMATINIB;AKOS 91378;IMA-3;IMATINIB-D3;Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;Imatinib Mesilate;4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;Imatinib mesylate;4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE;Imatinib (4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;Imatinib (CGP-57148B,CGP 57148,STI-571);Imatinib (STI571);N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide;1iep;1xbb;Imatinib free base;STI571;STI-571;UNII-BKJ8M8G5HI;Veenat;ST-1571;CGP057148B;IMatinib-D4;Imantinib base;IMATINIB 99+%;Cgp 57148;Imatinib [INN:BAN];STI 571;Imatinib Methansulfonate;Imatinib(STI571);CGP 57148B;BKJ8M8G5HI;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimi;CGP-57148B;HMS3244P10;HMS3244P10;152459-95-5;152459-95-5;DB00619;DB00619;Imatinib base;Imatinib base;4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide; CGP 57148; Genfatinib; Imatinib, Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide;4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide; CGP 57148; Genfatinib; Imatinib, Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide;N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide;HY-15463;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide;SB17306;HY-15463;NSC 759854;SB17306;NSC 759854;HMS3244P06;HMS3244P06;SY028029;SY028029;1080014-82-9;1080014-82-9;Gleevec (TN) (Novartis);Gleevec (TN) (Novartis);AB00698388-11;AB00698388-11;SR-01000763561-4;SR-01000763561-4;Q-201231;Q-201231;BRD-K92723993-066-22-7;BRD-K92723993-066-22-7;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate;4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate;Kinome_3724;Kinome_3724;Imatinib (INN);Imatinib (INN);D08066;D08066;MFCD05662257;MFCD05662257;AB00698388_16;AB00698388_16;EN300-123057;EN300-123057;SR-01000763561;SR-01000763561;cid_5291;cid_5291;STI-571; IMATINIB;STI-571; IMATINIB;BI164570;BI16457... |
微信公众号
客服
